The drug discount card market facilitates access to affordable prescription drugs for millions of uninsured and underinsured individuals across the United States. Drug discount or prescription savings cards help users save on out-of-pocket costs for their prescription medicines by negotiating discounts and rebates from pharmacies and pharmaceutical manufacturers. These cards allow users to buy generic and name brand drugs at reduced prices. Some cards have no monthly or annual fees and provide savings on all medications while others specialize in certain therapeutic areas or diseases. The Global Drug Discount Card Market is estimated to be valued at US$ 1,674.2 Mn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the drug discount card market are GoodRx, SingleCare, WellCard Savings, RxSaver, Optum Perks, Kroger Prescription Savings Club, ScriptSave, Walmart Rx Savings Program, Prescription Hope, FamilyWize, NeedyMeds, and Humana. These companies offer a wide variety of drug discount programs and services to millions of Americans struggling to afford their medications.
The growing demand for affordable healthcare in the United States is propelling growth of the drug discount card market. A major share of the population remains uninsured or underinsured and relies on discount programs to purchase costly patented and generic drugs for chronic conditions. Additionally, rising drug prices have made medication unaffordable for many even with insurance coverage pushing up demand for savings solutions.
The global expansion of leading drug discount card providers is another key trend in the market. Companies are actively partnering with local pharmacies and expanding accepted drug formularies to include more international brands. This allows discount services to benefit global patients and increases their consumer base beyond the United States. Cross-border alliances help lower drug costs for users worldwide.
Market Key Trends
The popularity of mobile applications for drug discount cards is a major trend witnessed in the market. Leading players have launched free mobile apps that allow users to easily search for savings on prescription drugs, scan codes to reveal prices, and store digitized benefit cards. The convenience of discount drug price information at one's fingertips is boosting consumer convenience and brand loyalty.
Porter’s Analysis
Threat of new entrants: New entrants face high costs of acquiring licenses to provide prescription drug discounts. Bargaining power of buyers: Individual customers have low bargaining power as there are limited options for prescription drug discounts. Bargaining power of suppliers: Pharmaceutical manufacturers have moderate bargaining power as drug discount card firms negotiate discounts and rebates on prescription drug prices. Threat of new substitutes: Substitute options are limited as pharmaceutical benefit managers have emerged as dominant negotiators for prescription drug prices and rebates. Competitive rivalry: Competition is intense as firms primarily compete on cost of memberships and depth of discounts negotiated with pharmacies and drug manufacturers.
Geographical Regions
The United States accounts for the major share of the global drug discount card market in terms of value as healthcare costs in the country are highest. Out-of-pocket costs for prescription drugs remain unaffordable for many without insurance subsidies or discount programs.
Europe is poised to be the fastest growing regional market for drug discount cards over the forecast period. Healthcare reforms in various European nations aim to reduce prescription drug costs and improve affordability for citizens. Subscription-based discount card programs offer a low-cost alternative to government-run pharmaceutical coverage programs.
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
No comments:
Post a Comment